Back to Search Start Over

Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity.

Authors :
de la Cruz-Morcillo MA
García-Cano J
Arias-González L
García-Gil E
Artacho-Cordón F
Ríos-Arrabal S
Valero ML
Cimas FJ
Serrano-Oviedo L
Villas MV
Romero-Fernández J
Núñez MI
Sánchez-Prieto R
Source :
Cancer letters [Cancer Lett] 2013 Jul 10; Vol. 335 (1), pp. 66-74. Date of Electronic Publication: 2013 Feb 08.
Publication Year :
2013

Abstract

The p38 Mitogen Activated Protein Kinase (MAPK) signaling pathway has become a major player in the response to DNA-damage. A growing body of evidences has been relating this signaling pathway to the cellular response to ionizing radiation (IR), suggesting a role in radioresistance. Here, we study the implication of this signaling pathway in the response to IR in terms of radioresistance. To this end we used 10 different cell lines derived from several types of tumors (colorectal, non-small cell lung cancer -NSCLC-, renal and glioblastoma). Although p38 MAPK is transiently activated by IR, our data, obtained by genetic and chemical approaches, showed that this signaling pathway is not implicated in cellular viability after IR exposure. Indeed, down-modulation of this signaling pathway promotes a mild radiosensitivity depending on the cell line. However, it is remarkable that lack of p38 MAPK α abrogates the radiosensitizing effect of 5-Fluorouracil (5-FU) in HCT116 cell line, supporting the role of this MAPK in the radiosensitizing action of 5-FU.<br /> (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1872-7980
Volume :
335
Issue :
1
Database :
MEDLINE
Journal :
Cancer letters
Publication Type :
Academic Journal
Accession number :
23403078
Full Text :
https://doi.org/10.1016/j.canlet.2013.01.050